The Ozempic and Wegovy mistake sending thousands to poison control

According to ScienceDaily, poison control centers have seen a surge in calls involving semaglutide—the active ingredient in Ozempic and Wegovy—since the drugs were approved for weight management. Researchers found that accidental dosing errors, not intentional misuse, are driving the increase. Simple education about proper weekly dosing and gradual dose escalation could prevent many of these avoidable incidents.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton